Active, Not Recruiting
Study to Evaluate the Safety, Tolerability, PK Characteristics and Anti-tumor Activity of FCN-159 in Adult and Pediatric Participants With Neurofibromatosis Type 1
NCT04954001
- Conditions
- Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Heredodegenerative Disorders, Nervous System, +18 more
- Locations
-
- Children's Hospital Los Angeles Los Angeles, California, United States
- Principal Investigator Hans Gainesville, Florida, United States
- John Hopkins All Children Hospital St. Petersburg, Florida, United States
- Henry Ford Health System Detroit, Michigan, United States